Positron Emission Tomography Shows Elevated Cannabinoid CB1 Receptor Binding in Men with Alcohol Dependence
Alcoholism: Clinical and Experimental Research, 05/07/2012Neumeister A et al.
The findings agree with preclinical evidence and provide the first, albeit still preliminary in vivo evidence suggesting a role for brain cannabinoid type 1 (CB1) receptors in alcohol dependence (AD). The current study design does not answer the important question of whether elevated CB1 receptors are a preexisting vulnerability factor for AD or whether elevations develop as a consequence of AD.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.